PRME earnings date and last-quarter result: next report 2026-08-06, last quarter miss, P/E -2.44. Updated 2026-07-23.
Prime Medicine (PRME) Research Hub
Prime Medicine (PRME) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 3.61 USD (-1.63%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -2.44, market cap 0.55B. This hub links to the full technical, earnings and options research available for PRME.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 3.61 USD (-1.63%) |
| 52-week range | 2.77 USD – 4.73 USD |
| Trend regime | Range |
| 14-day RSI | 51.6 (Neutral) |
| Trailing P/E | -2.44 |
| Market cap | 0.55B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-06 |
Available research for PRME
Covered Call on PRME: how it works, illustrative setup around the real 3.61 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on PRME: how it works, illustrative setup around the real 3.61 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on PRME: how it works, illustrative setup around the real 3.61 USD price, max profit/loss, breakeven and when to use it. Educational.
PRME technical analysis: range, last 3.61 USD, RSI 51.6, 52w range 2.77 USD–4.73 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is PRME in?
Prime Medicine (PRME) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is PRME in an uptrend or downtrend?
As of 2026-10-26, PRME is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is PRME's trailing P/E ratio?
PRME's trailing P/E is -2.44, with a market cap of 0.55B. See the earnings research page for full valuation detail.
When does PRME next report earnings?
PRME is next scheduled to report earnings on 2026-08-06.